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Here, we report the draft genome sequence of Kluyveromyces marxianus fragilis B0399, the first yeast approved as a probiotic for
human consumption not belonging to the genus Saccharomyces. The genome is composed of 8 chromosomes, with a total size of
11.44Mb, including mitochondrial DNA.
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The probiotic lactic yeast Kluyveromyces marxianus fragilisB0399 (TURVAL B0399) is a strain belonging to a species nat-
urally occurring in kefir and cheese, which is isolated from whey
and curds of cow milk. It is the first yeast not belonging to the
genus Saccharomyces with probiotic activity that has appeared in
the market, and it was approved as a probiotic for both animal
feeding (1) and human consumption (2). This strain was
shown to remain viable after consumption, surpassing the gas-
tric barrier and colonizing the gut adhering to the enterocytes
of the intestinal epithelium (3). Moreover, it regulates intesti-
nal activity during antibiotic therapy, thanks to the yeast in-
trinsic resistance to bacterium-targeting antibiotics (4). Fur-
thermore, its -galactosidase activity, absent in strains of the
genus Saccharomyces, permits the degradation of lactose, gener-
ating glucose and galactose; therefore, it is useful in lowering the
effects of lactose intolerance in susceptible individuals (5). Several
in vitro (3) and in vivo (4, 6) experimental evidences demonstrated
that K. marxianus B0399 is able to modulate the immune re-
sponse, reducing the proinflammatory cytokine levels, thus being
useful for mitigation of the effect of several diseases, such as irri-
table bowel syndrome (6, 7).
Sequencing of its genomewas performed to gainmore detailed
information on its characteristics as a probiotic and to broaden
knowledge on the genomic biodiversity in the species K. marxia-
nus, since other strains whose genome sequences are available are
used for bioethanol production or other applications (8–10).
Microbial DNA, isolated using theWizard Genomic DNA pu-
rification kit (Promega), was used to construct three libraries with
insert sizes of 578 nucleotides (nt), 626 nt, and 5 kb, which were
amplified and sequenced using the Illumina HiSeq 2000 at IGA
Technology Services (Udine, Italy), producing clean data contain-
ing 20 million paired reads with 150 nt at 270-fold coverage.
Trimmed reads were de novo assembled using AllPaths-LG ver-
sion 48359 (11) with default parameters, except for TARGETS 
Std., HAPLOIDIFY  T, CLOSE_UNIPATH_GAPSF, DRY_
RUNF, MIN_CONTIG500, and MAX_MEMORY_GB120.
The contigs were scaffolded using IMR/DENOM version 0.4.0f
(12) and ordered by ScaPA release 3 (IGA Technology Services)
using the genome of K. marxianus NBRC1777 (GenBank acces-
sion numbers AP014599 to AP014607) as a reference.
The genome sequence of B0399 was 11.44 Mb, and the GC
content was 40%. The genome was composed of eight chromo-
somes, including mitochondrial DNA. The assembly generated
109 scaffolds, with amaximum length of 1.3Mb and anN50 length
of 743,117 bases. A total of 5,373 putative proteins ofK.marxianus
B0399 were predicted using tBLASTn analysis against the refer-
ence genome. The key enzyme for lactose degradation (-
galactosidase) was highly similar to the corresponding enzyme
from Kluyveromyces lactis, confirming that this yeast can be suc-
cessfully used for the reduction of the effects of lactose intolerance
in susceptible individuals.
Accession number(s). This whole-genome shotgun project
has been deposited at DDBJ/ENA/GenBank under the accession
no. LXZY00000000. The version described in this paper is the first
version.
FUNDING INFORMATION
This researchwas funded by theUniversity of Verona and by the company
Laboratori Turval S.r.l. (Udine, Italy) in the framework of Joint-Project
2014, For Optimized ResisTance of fragilIS Kluyveromyces (FORTIS-
Klu), of the University of Verona.
REFERENCES
1. EFSA. 2004. Opinion of the Scientific Panel on additives and products or
substances used in animal feed (FEEDAP) on the safety of the micro-
organismproduct Turval B0399 for use as feed additive forweaned piglets.
Question n. EFSA-2003-051. EFSA J 28:1–6. http://dx.doi.org/10.2903/
j.efsa.2004.28.
2. Ministero della Salute. 2016. Registro degli integratori alimentari. Min-
istero della Salute, Rome, Italy. http://www.salute.gov.it/portale/temi/p2
_6.jsp?id3668&areaAlimenti%20particolari%20e%20integratori&m
enuregistri.
3. Maccaferri S, Klinder A, Brigidi P, Cavina P, Costabile A. 2012. Potential
probiotic Kluyveromyces marxianus B0399 modulates the immune response
in Caco-2 cells and peripheral blood mononuclear cells and impacts the hu-
man gut microbiota in an in vitro colonic model system. Appl Environ Mi-
crobiol 78:956–964. http://dx.doi.org/10.1128/AEM.06385-11.
crossmark
Genome AnnouncementsSeptember/October 2016 Volume 4 Issue 5 e00923-16 genomea.asm.org 1
4. Maccaferri S, Candela M, Turroni S, Centanni M, Severgnini M, Con-
solandi C, Cavina P, Brigidi P. 2012. IBS-associated phylogenetic unbal-
ances of the intestinal microbiota are not reverted by probiotic supple-
mentation. Gut Microbes 3:406 – 413. http://dx.doi.org/10.4161/
gmic.21009.
5. Fonseca GG, Heinzle E, Wittmann C, Gombert AK. 2008. The yeast
Kluyveromyces marxianus and its biotechnological potential. Appl Microbiol
Biotechnol 79:339–354. http://dx.doi.org/10.1007/s00253-008-1458-6.
6. Lisotti A, Cornia GL, Morselli-Labate AM, Sartini A, Turco L, Grasso V,
Cavina P, Mazzella G, Roda E. 2011. Effects of a fermented milk containing
Kluyveromyces marxianus B0399 and Bifidobacterium lactis BB12 in patients
with irritable bowel syndrome.MinervaGastroenterolDietol 57:1–12. http://
dx.doi.org/10.1016/S0016-5085(13)61999-X.
7. Nigro A, Nicastro A, Trodella R. 2014. Retrospective observational study
to investigate Sinerga, a multifactorial nutritional product, and bacterial
extracts in the prevention of recurrent respiratory infections in children.
Int J Immunopathol Pharmacol 27:455– 460. doi :10.1177/
039463201402700318.
8. Silveira WB, Diniz RHS, Cerdán ME, González-Siso MI, Souza Rde A,
Vidigal PMP, Brustolini OJB, Prata ERBdeA, Medeiros AC, Paiva LC,
Nascimento M, Ferreira EG, dos Santos VC, Bragança CRS, Fernandes
TAR, Colombo LT, Passos FML. 2014. Genomic sequence of the yeast
KluyveromycesmarxianusCCT7735 (UFV-3), a highly lactose-fermenting
yeast isolated from the Brazilian dairy industry. Genome Announc 2(6):
e01136-14. http://dx.doi.org/10.1128/genomeA.01136-14.
9. Suzuki T, Hoshino T, Matsushika A. 2014. Draft genome sequence of
Kluyveromyces marxianus strain DMB1, isolated from sugarcane bagasse
hydrolysate. Genome Announc 2(4):e00733-14. http://dx.doi.org/
10.1128/genomeA.00733-14.
10. Inokuma K, Ishii J, Hara KY, Mochizuki M, Hasunuma T, Kondo A.
2015. Complete genome sequence of Kluyveromyces marxianus
NBRC1777, a nonconventional thermotolerant yeast. Genome Announc
3(2):e00389-15. http://dx.doi.org/10.1128/genomeA.00389-15.
11. Gnerre S, MacCallum I, Przybylski D, Ribeiro FJ, Burton JN, Walker
BJ, Sharpe T, Hall G, Shea TP, Sykes S, Berlin AM, Aird D, Costello M,
Daza R, Williams L, Nicol R, Gnirke A, Nusbaum C, Lander ES, Jaffe
DB. 2011. High-quality draft assemblies of mammalian genomes from
massively parallel sequence data. ProcNatl Acad Sci U SA 108:1513–1518.
http://dx.doi.org/10.1073/pnas.1017351108.
12. Gan X, Stegle O, Behr J, Steffen JG, Drewe P, Hildebrand KL, Lyngsoe
R, Schultheiss SJ, Osborne EJ, Sreedharan VT, Kahles A, Bohnert R,
Jean G, Derwent P, Kersey P, Belfield EJ, Harberd NP, Kemen E,
Toomajian C, Kover PX, Clark RM, Rätsch G, Mott R. 2011. Multiple
reference genomes and transcriptomes for Arabidopsis thaliana. Nature
477:419–423. http://dx.doi.org/10.1038/nature10414.
Quarella et al.
Genome Announcements2 genomea.asm.org September/October 2016 Volume 4 Issue 5 e00923-16
